Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Translational Biomarkers and Therapeutic Development for Very Young Children Diagnosed With Autism Spectrum Disorder and Co-occurring Anxiety

NCT06221176 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.

NCT NCT06221176
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06221176 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Translational Biomarkers and Therapeutic Development for Very Young Children Diagnosed With Autism Spectrum Disorder and Co-occurring Anxiety
Lead sponsor
Boston Children's Hospital
Phase
Not applicable
Overall status
Completed
Start date
April 2, 2024
Completion date
June 1, 2026
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism, autism spectrum disorder